只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-15 2026-07-17 | KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. | Webster Brian Daniel Director,Officer · See Remarks | 卖出（S） | 11,216 | US$22.01 | US$246,869.77 | 560,721 | SEC |
| 2026-07-15 2026-07-17 | KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. | Webster Brian Daniel Director,Officer · See Remarks | 卖出（S） | 784 | US$22.63 | US$17,744.51 | 559,937 | SEC |
| 2026-07-15 2026-07-17 | KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. | Webster Brian Daniel Director,Officer · See Remarks | 卖出（S） | 3,000 | US$24.00 | US$71,994.90 | 556,937 | SEC |
| 2026-06-30 2026-07-01 | PCSA Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL Officer · Chief Financial Officer | 买入（P） | 3,277 | US$1.93 | US$6,324.61 | 16,689 | SEC |
| 2026-06-15 2026-06-17 | KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. | Webster Brian Daniel Director,Officer · See Remarks | 卖出（S） | 15,000 | US$20.81 | US$312,150.00 | 395,467 | SEC |
| 2026-06-15 2026-06-16 | PCSA Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL Officer · Chief Financial Officer | 买入（P） | 2,654 | US$2.22 | US$5,891.88 | 13,412 | SEC |
| 2026-06-08 2026-06-10 | DDOG Datadog, Inc. | OBSTLER DAVID M Officer · Chief Financial Officer | 卖出（S） | 2,783 | US$234.31 | US$652,084.73 | 437,508 | SEC |
| 2026-06-08 2026-06-10 | DDOG Datadog, Inc. | OBSTLER DAVID M Officer · Chief Financial Officer | 卖出（S） | 2,217 | US$235.35 | US$521,770.95 | 435,291 | SEC |
| 2026-06-08 2026-06-10 | DDOG Datadog, Inc. | OBSTLER DAVID M Officer · Chief Financial Officer | 卖出（S） | 100 | US$236.20 | US$23,620.00 | 435,191 | SEC |
| 2026-06-08 2026-06-10 | DDOG Datadog, Inc. | OBSTLER DAVID M Officer · Chief Financial Officer | 卖出（S） | 600 | US$239.13 | US$143,478.00 | 434,591 | SEC |
| 2026-06-08 2026-06-10 | DDOG Datadog, Inc. | OBSTLER DAVID M Officer · Chief Financial Officer | 卖出（S） | 10,054 | US$233.31 | US$234.57万 | 440,291 | SEC |
| 2026-06-08 2026-06-10 | DDOG Datadog, Inc. | OBSTLER DAVID M Officer · Chief Financial Officer | 卖出（S） | 21,382 | US$231.31 | US$494.59万 | 462,743 | SEC |
| 2026-06-08 2026-06-10 | DDOG Datadog, Inc. | OBSTLER DAVID M Officer · Chief Financial Officer | 卖出（S） | 17,966 | US$230.59 | US$414.28万 | 484,125 | SEC |
| 2026-06-08 2026-06-10 | DDOG Datadog, Inc. | OBSTLER DAVID M Officer · Chief Financial Officer | 卖出（S） | 7,500 | US$229.29 | US$171.97万 | 502,091 | SEC |
| 2026-06-08 2026-06-10 | DDOG Datadog, Inc. | OBSTLER DAVID M Officer · Chief Financial Officer | 卖出（S） | 12,398 | US$232.41 | US$288.14万 | 450,345 | SEC |
| 2026-06-02 2026-06-04 | DDOG Datadog, Inc. | OBSTLER DAVID M Officer · Chief Financial Officer | 卖出（S） | 16,323 | US$267.15 | US$436.07万 | 509,591 | SEC |
| 2026-05-29 2026-06-01 | PCSA Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL Officer · Chief Financial Officer | 买入（P） | 2,292 | US$2.57 | US$5,890.44 | 10,758 | SEC |
| 2026-05-21 2026-05-22 | ALGM ALLEGRO MICROSYSTEMS, INC. | Webster Roald Graham Officer · VP, Chief Accounting Officer | 卖出（S） | 5,217 | US$44.89 | US$234,191.13 | 13,106 | SEC |
| 2026-05-18 2026-05-20 | WBS WEBSTER FINANCIAL CORP | CIULLA JOHN R Director,Officer · Chairman and CEO | 卖出（S） | 8,000 | US$71.67 | US$573,360.00 | 289,838 | SEC |
| 2026-05-15 2026-05-19 | PCSA Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL Officer · Chief Financial Officer | 买入（P） | 1,984 | US$2.97 | US$5,892.48 | 8,466 | SEC |
| 2026-05-15 2026-05-18 | KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. | Webster Brian Daniel Director,Officer · See Remarks | 卖出（S） | 6,845 | US$21.46 | US$146,893.70 | 334,786 | SEC |
| 2026-05-15 2026-05-18 | KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. | Webster Brian Daniel Director,Officer · See Remarks | 卖出（S） | 8,155 | US$20.53 | US$167,422.15 | 341,631 | SEC |
| 2026-04-30 2026-05-01 | PCSA Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL Officer · Chief Financial Officer | 买入（P） | 2,190 | US$2.69 | US$5,891.10 | 6,498 | SEC |
| 2026-04-15 2026-04-17 | PCSA Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL Officer · Chief Financial Officer | 买入（P） | 1,984 | US$2.97 | US$5,892.48 | 4,308 | SEC |
| 2026-04-15 2026-04-16 | KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. | Webster Brian Daniel Director,Officer · See Remarks | 卖出（S） | 15,000 | US$20.04 | US$300,600.00 | 349,786 | SEC |
| 2026-03-31 2026-04-01 | PCSA Processa Pharmaceuticals, Inc. | SKIBSTED RUSSELL Officer · Chief Financial Officer | 买入（P） | 2,324 | US$2.54 | US$5,902.96 | 2,324 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| BSTV | 106 | 0 | 110.3586 | 96.05% | Q |
| BSTP | 4,302 | 0 | 4,497 | 95.66% | Q, N |
| BSTS | 2 | 0 | 2.1496 | 93.04% | Q |
| YBST | 284 | 0 | 403.3901 | 70.40% | Q, N |
| BSTU | 4 | 0 | 7.5555 | 52.94% | Q |
| BSTZ | 42,244.6434 | 0 | 91,707.8019 | 46.06% | B, Q, N |
| BST | 18,810.1214 | 0 | 53,032.2477 | 35.47% | B, Q, N |